ORTEXORTEX News
Tracking RZLV? Get live short interest, options flow, and signals on ORTEX.Sign up free →
RZ
Earnings PreviewRZLV

RZLV Bears Hold Ground With Three Days to the Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 27 Jul 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Rezolve AI arrives at Wednesday's earnings with the same contradiction that has defined the past two weeks — short sellers adding aggressively, options traders buying calls — but with the positions now locked in and the clock nearly expired.

The short-side story has not changed direction since the last note, only intensified. Short interest closed July 23 at 12.7% of free float, representing 38.2 million shares — a full recovery of the mid-July unwind and a 21.5% increase on the week. The ORTEX short score has climbed every session this week to 75.9, ranking the stock in the third percentile of the universe for short-side pressure. Borrow availability tightened further to 22.8%, meaning roughly one share remains available for every four already lent out, down from 25.4% a week ago. Cost to borrow edged up to 15.9% APR — elevated, but a fraction of the 200%-plus readings from late June. The borrow market is tight enough to constrain new short entry, but not tight enough to force a mechanical squeeze.

Options positioning diverges sharply from that bearish read. The put/call ratio has fallen to 0.24, near the 52-week low and roughly 1.7 standard deviations below its 20-day average. That signals call buyers are dominating the options flow — investors paying for upside exposure into the print rather than hedging against downside. The PCR has been sliding steadily since mid-July, when it was running near 0.29-0.30. The gap between the short book and the options flow is the defining tension into Wednesday.

The bull case rests on Rezolve's growth trajectory. Revenue reportedly grew more than 1,000% year-on-year, and bulls project further acceleration through direct sales and AI partnership deals. The bear case is structural: the company generates deeply negative free cash flow, carries a negative EV/EBITDA, and dilution risk remains a recurring concern. Institutional ownership is concentrated — the top three disclosed holders account for roughly 28% of shares — which limits the natural float and amplifies any post-earnings move in either direction. Insider buying from the CEO and a director earlier this year totalled over $3.5 million, providing some signal of internal conviction, though at prices well above the current $2.24 close.

Recent earnings reactions have been mixed but tend to produce meaningful moves: the June 2026 print generated a 3.2% one-day gain and nearly 10% over five sessions, while the April 8 event saw an 11.8% single-day drop. The July 30 print will test whether bears who rebuilt 10.8 million shares in just over a week were right to fade the growth story — or whether call buyers collected the premium.

Stocks in this article

See the live data behind this article on ORTEX.

Open RZLV on ORTEX →

How this article was generated

Generated
27 Jul 2026, 04:40
Data as of
27 Jul 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.